← Home / Foghorn Therapeutics Inc. (FHTX)
Stock Analysis
Foghorn Therapeutics Inc. (FHTX)
FHTX
FHTX · Market data
5.95 -1.00%
52W Range Position
77%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-12 19:57 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 6.68. Holding above 4.85 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
4.85
↗
Break Above
Confirmation improves above resistance.
6.68
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 4.85
What's Driving FHTX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 6.68 for confirmation and 4.85 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 4.85 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
72.6
Price Chart
FHTX · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-10
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$349.3M
Company size
EV
$281.9M
Debt-adjusted value
P/E
-4.6
Not meaningful
P/S
12.4
Premium
P/B
-4.6
Not meaningful
EV/Sales
10.0
Balanced
EV/EBIT
-3.3
Not meaningful
P/FCF
-4.0
Not meaningful
FCF Yield
-25.03%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Strong
💵 Revenue
3.27M
↘ Weak
📈 Net Income
-19.88M
↘ Negative
🧮 EPS (Basic)
-0.29
↘ Negative
Foghorn Therapeutics Inc.
Related Opportunities